Stories for Change: Digital Storytelling as a Tool for Engagement in Facilitated Discussion for Diabetes

NCT02969954 | Completed

• 1 other identifier: 16-005091
• Study Type: interventional
• Target: 22
• Locations: 1 country
• Sites: 1

Brief Summary

Racial and ethnic minorities with type II diabetes in the US are more likely to develop complications and die from the disease than the general population. The foreign-born subset of this population is less likely to adhere to diabetes care recommendations than US-born patients, thereby placing them at higher risk for complications. In our previous pilot project, eight stories were assessed through preliminary multi-site intervention for acceptability and efficacy in diabetes management among Latino and Somali patients with poorly controlled type II diabetes. The goal of this project is to evaluate a new format for delivery of a culturally tailored digital storytelling intervention by incorporating a facilitated group discussion following the videos, for management of type II diabetes in Latino communities.

Conditions

Diabetes Mellitus

Outcome Measures

Primary Outcomes (1)

• Self-efficacy for diabetes management

  The evaluation will assess the degree to which the intervention motivates the patient to improve self-management of diabetes. The evaluation will also assess overall acceptability. Items for this survey were adapted from a well validated health communication assessment tool produced by the National Cancer Institute.

  Assessment will be done immediately after participants watch the intervention video

Study Arms (1)

Intervention arm

EXPERIMENTAL

Study has one arm - who will all receive the intervention

Other: Self-efficacy for diabetes management

Interventions

Self-efficacy for diabetes management OTHER

Participants at both sites will watch a 12 minute video featuring the digital stories on diabetes. Following the video, participants will engage in a brief facilitated discussion regarding motivations and barriers to diabetes management, led by a trained Spanish-speaking facilitator.

Intervention arm

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Self-identify as Hispanic/Latino
• Are Spanish-speaking
• Receive primary care at one of the participating clinical sites
• Self-reported diagnosis of type II diabetes

You may not qualify if:

• Not able to give informed consent
• Not able to participate in a group discussion

Sponsors & Collaborators

• Mayo Clinic: lead

Study Sites (1)

Mayo Clinic in Rochester

Rochester, Minnesota, 55905, United States

Location

MeSH Terms

Conditions

Diabetes Mellitus

Condition Hierarchy (Ancestors)

Glucose Metabolism Disorders; Metabolic Diseases; Nutritional and Metabolic Diseases; Endocrine System Diseases

Study Officials

• Jane W Njeru

  Mayo Clinic

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: PI

Study Record Dates

• First Submitted: November 16, 2016
• First Posted: November 21, 2016
• Study Start: November 1, 2016
• Primary Completion: December 1, 2017
• Study Completion: December 1, 2017
• Last Updated: February 14, 2018

Record last verified: 2018-02

Locations

US (1)